These results indicate that STAG2 is critical for SMC3 acetylation independent of p53 function, and that cancer cells with concomitant STAG2 and TP53 inactivation escape cellular senescence despite abrogation of SMC3 acetylation. This evidence concerns the gene TP53 and cancer.